Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nuwellis stocks are traded under the ticker 22S0.F.
When is the next Nuwellis earnings date?▼
Nuwellis is going to release the next earnings report on May 12, 2026.
What were Nuwellis earnings last quarter?▼
22S0.F earnings for the last quarter are -1.29 EUR per share, whereas the estimation was -1.34 EUR resulting in a +3.85% surprise. The estimated earnings for the next quarter are N/A EUR per share.
When did Nuwellis complete a stock split?▼
The last stock split for Nuwellis was on July 07, 2025 with a ratio of 1:42.